image
Healthcare - Medical - Devices - NASDAQ - US
$ 70.98
0 %
$ 3.63 B
Market Cap
-709.8
P/E
1. INTRINSIC VALUE

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally.[ Read More ]

The intrinsic value of one AXNX stock under the base case scenario is HIDDEN Compared to the current market price of 71 USD, Axonics, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart AXNX

image
FINANCIALS
366 M REVENUE
33.86%
-26.1 M OPERATING INCOME
38.52%
-6.09 M NET INCOME
89.80%
-2.02 M OPERATING CASH FLOW
-63.18%
-117 M INVESTING CASH FLOW
2.87%
-3.38 M FINANCING CASH FLOW
-2.52%
116 M REVENUE
1.42%
-6.27 M OPERATING INCOME
-98.97%
-21 K NET INCOME
-0.30%
922 K OPERATING CASH FLOW
-94.57%
70.1 M INVESTING CASH FLOW
190.87%
2.52 M FINANCING CASH FLOW
947.72%
Balance Sheet Decomposition Axonics, Inc.
image
Current Assets 491 M
Cash & Short-Term Investments 345 M
Receivables 57.2 M
Other Current Assets 89.2 M
Non-Current Assets 229 M
Long-Term Investments 0
PP&E 33.3 M
Other Non-Current Assets 195 M
Current Liabilities 45.8 M
Accounts Payable 18.5 M
Short-Term Debt 3.55 M
Other Current Liabilities 23.8 M
Non-Current Liabilities 36.5 M
Long-Term Debt 25.8 M
Other Non-Current Liabilities 10.7 M
EFFICIENCY
Earnings Waterfall Axonics, Inc.
image
Revenue 366 M
Cost Of Revenue 91.8 M
Gross Profit 275 M
Operating Expenses 270 M
Operating Income -26.1 M
Other Expenses -20 M
Net Income -6.09 M
RATIOS
74.94% GROSS MARGIN
74.94%
-7.11% OPERATING MARGIN
-7.11%
-1.66% NET MARGIN
-1.66%
-0.95% ROE
-0.95%
-0.85% ROA
-0.85%
-2.84% ROIC
-2.84%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Axonics, Inc.
image
Net Income -6.09 M
Depreciation & Amortization 13.4 M
Capital Expenditures -3.55 M
Stock-Based Compensation 44.5 M
Change in Working Capital -66.1 M
Others -18.1 M
Free Cash Flow -5.57 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Axonics, Inc.
image
Wall Street analysts predict an average 1-year price target for AXNX of $71 , with forecasts ranging from a low of $71 to a high of $71 .
AXNX Lowest Price Target Wall Street Target
71 USD 0.03%
AXNX Average Price Target Wall Street Target
71 USD 0.03%
AXNX Highest Price Target Wall Street Target
71 USD 0.03%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Axonics, Inc.
image
Sold
0-3 MONTHS
206 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7.19 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Oct 02, 2024
Sell 25.3 K USD
Keese Kari Leigh
Chief Financial Officer
- 364
69.4047 USD
1 month ago
Oct 02, 2024
Sell 180 K USD
Keese Kari Leigh
Chief Financial Officer
- 2597
69.4066 USD
9 months ago
Jan 31, 2024
Sell 765 K USD
Noblett Karen
Chief Medical Officer
- 11288
67.7359 USD
9 months ago
Jan 31, 2024
Sell 1.08 M USD
Woock John
EVP, Chief Mktg/Strtgy Officer
- 15899
67.7359 USD
9 months ago
Jan 31, 2024
Sell 1.13 M USD
Ford Alfred J Jr
Chief Commercial Officer
- 16615
67.7359 USD
9 months ago
Jan 31, 2024
Sell 236 K USD
Keese Kari Leigh
Chief Financial Officer
- 3489
67.7359 USD
9 months ago
Jan 31, 2024
Sell 2.38 M USD
COHEN RAYMOND W
Chief Executive Officer
- 35161
67.7359 USD
10 months ago
Jan 08, 2024
Sell 1.1 M USD
Noblett Karen
Chief Medical Officer
- 15999
69.0019 USD
10 months ago
Dec 26, 2023
Sell 59.8 K USD
Noblett Karen
Chief Medical Officer
- 949
63 USD
10 months ago
Dec 28, 2023
Sell 446 K USD
Noblett Karen
Chief Medical Officer
- 7051
63.2785 USD
1 year ago
Sep 29, 2023
Sell 436 K USD
Dearen Danny L.
President & CFO
- 7675
56.8717 USD
2 years ago
Feb 03, 2022
Sell 855 K USD
Dearen Danny L.
President & CFO
- 17737
48.2103 USD
2 years ago
Feb 03, 2022
Sell 46.4 K USD
Dearen Danny L.
President & CFO
- 947
49.0347 USD
1 year ago
Aug 15, 2023
Sell 921 K USD
Ford Alfred J Jr
Chief Commercial Officer
- 14769
62.3381 USD
1 year ago
Jul 28, 2023
Sell 93 K USD
Ford Alfred J Jr
Chief Commercial Officer
- 1500
62.014 USD
1 year ago
May 26, 2023
Sell 381 K USD
Dearen Danny L.
President & CFO
- 7699
49.4355 USD
1 year ago
May 26, 2023
Sell 15 K USD
Dearen Danny L.
President & CFO
- 300
50.14 USD
1 year ago
Apr 21, 2023
Sell 621 K USD
Dearen Danny L.
President & CFO
- 10363
59.9308 USD
1 year ago
Apr 21, 2023
Sell 583 K USD
Dearen Danny L.
President & CFO
- 9637
60.5037 USD
1 year ago
Apr 20, 2023
Sell 120 K USD
Dearen Danny L.
President & CFO
- 2001
60.0063 USD
1 year ago
Mar 31, 2023
Sell 395 K USD
Dearen Danny L.
- 7198
54.8346 USD
1 year ago
Mar 31, 2023
Sell 434 K USD
Dearen Danny L.
- 7802
55.6785 USD
1 year ago
Feb 21, 2023
Sell 912 K USD
Sama Rinda
- 16229
56.176 USD
1 year ago
Feb 21, 2023
Sell 210 K USD
Sama Rinda
- 3700
56.685 USD
1 year ago
Feb 21, 2023
Sell 192 K USD
Sama Rinda
- 3392
56.53 USD
1 year ago
Jan 31, 2023
Sell 477 K USD
Sama Rinda
- 7791
61.1694 USD
1 year ago
Jan 31, 2023
Sell 344 K USD
Sama Rinda
- 5634
61.1219 USD
1 year ago
Feb 01, 2023
Sell 44.8 K USD
Sama Rinda
- 741
60.4347 USD
1 year ago
Feb 01, 2023
Sell 264 K USD
Sama Rinda
- 4334
61.016 USD
1 year ago
Jan 31, 2023
Sell 259 K USD
Ford Alfred J Jr
- 4235
61.1694 USD
1 year ago
Jan 31, 2023
Sell 122 K USD
Ford Alfred J Jr
- 1999
61.1219 USD
1 year ago
Feb 01, 2023
Sell 32.7 K USD
Ford Alfred J Jr
- 541
60.4347 USD
1 year ago
Feb 01, 2023
Sell 193 K USD
Ford Alfred J Jr
- 3164
61.016 USD
1 year ago
Jan 31, 2023
Sell 477 K USD
Dearen Danny L.
- 7791
61.1694 USD
1 year ago
Jan 31, 2023
Sell 166 K USD
Dearen Danny L.
- 2720
61.1219 USD
1 year ago
Feb 01, 2023
Sell 28.6 K USD
Dearen Danny L.
- 474
60.4347 USD
1 year ago
Feb 01, 2023
Sell 169 K USD
Dearen Danny L.
- 2772
61.016 USD
1 year ago
Jan 31, 2023
Sell 849 K USD
COHEN RAYMOND W
- 13872
61.1694 USD
1 year ago
Jan 31, 2023
Sell 552 K USD
COHEN RAYMOND W
- 9032
61.1219 USD
1 year ago
Feb 01, 2023
Sell 71.6 K USD
COHEN RAYMOND W
- 1185
60.4347 USD
1 year ago
Feb 01, 2023
Sell 423 K USD
COHEN RAYMOND W
- 6932
61.016 USD
1 year ago
Jan 31, 2023
Sell 133 K USD
Noblett Karen
- 2167
61.1694 USD
1 year ago
Jan 31, 2023
Sell 93.9 K USD
Noblett Karen
- 1536
61.1219 USD
1 year ago
Feb 01, 2023
Sell 8.22 K USD
Noblett Karen
- 136
60.4347 USD
1 year ago
Feb 01, 2023
Sell 48.5 K USD
Noblett Karen
- 795
61.016 USD
1 year ago
Jan 31, 2023
Sell 207 K USD
Woock John
- 3389
61.1694 USD
1 year ago
Jan 31, 2023
Sell 256 K USD
Woock John
- 4181
61.1219 USD
1 year ago
Feb 01, 2023
Sell 35.1 K USD
Woock John
- 581
60.4347 USD
1 year ago
Feb 01, 2023
Sell 207 K USD
Woock John
- 3398
61.016 USD
1 year ago
Jan 17, 2023
Sell 811 K USD
Woock John
director: EVP, Chief Mktg/Strtgy Officer
- 12044
67.3175 USD
1 year ago
Jan 13, 2023
Sell 1.22 M USD
COHEN RAYMOND W
director: Chief Executive Officer
- 18684
65.5409 USD
1 year ago
Jan 13, 2023
Sell 1.46 M USD
COHEN RAYMOND W
director: Chief Executive Officer
- 22052
66.2722 USD
1 year ago
Jan 13, 2023
Sell 1.01 M USD
Ford Alfred J Jr
director: Chief Commercial Officer
- 15292
65.8972 USD
1 year ago
Jan 13, 2023
Sell 1.14 M USD
Ford Alfred J Jr
director: Chief Commercial Officer
- 17108
66.6866 USD
1 year ago
Jan 13, 2023
Sell 243 K USD
Ford Alfred J Jr
director: Chief Commercial Officer
- 3615
67.1759 USD
1 year ago
Dec 13, 2022
Sell 135 K USD
Lopez Esteban
Director
- 2000
67.42 USD
2 years ago
Sep 12, 2022
Sell 2.54 M USD
Noblett Karen
Chief Medical Officer
- 32483
78.1578 USD
2 years ago
Sep 07, 2022
Sell 748 K USD
Noblett Karen
Chief Medical Officer
- 10454
71.5319 USD
2 years ago
Aug 25, 2022
Sell 39.7 K USD
Woock John
director: Chief Marketing Officer
- 542
73.3369 USD
2 years ago
Aug 11, 2022
Sell 1.16 M USD
Dearen Danny L.
director: See Remarks
- 16280
71.2637 USD
2 years ago
Aug 10, 2022
Sell 636 K USD
Woock John
director: Chief Marketing Officer
- 9151
69.4623 USD
2 years ago
Aug 10, 2022
Sell 657 K USD
Sama Rinda
director: Chief Operating Officer
- 9372
70.12 USD
2 years ago
Aug 08, 2022
Sell 1.26 M USD
COHEN RAYMOND W
director: Chief Executive Officer
- 18100
69.4976 USD
2 years ago
Aug 08, 2022
Sell 851 K USD
COHEN RAYMOND W
Chief Executive Officer
- 12092
70.4015 USD
2 years ago
Aug 08, 2022
Sell 862 K USD
COHEN RAYMOND W
Chief Executive Officer
- 12032
71.6504 USD
2 years ago
Aug 08, 2022
Sell 128 K USD
COHEN RAYMOND W
Chief Executive Officer
- 1776
72.0873 USD
2 years ago
Aug 05, 2022
Sell 899 K USD
Sama Rinda
director: Chief Operating Officer
- 12694
70.8555 USD
2 years ago
Apr 01, 2022
Sell 110 K USD
Kiernan Jane E
Director
- 1750
62.71 USD
2 years ago
Apr 01, 2022
Sell 110 K USD
Kiernan Jane E
Director
- 1750
62.71 USD
2 years ago
Jul 05, 2022
Sell 315 K USD
Kiernan Jane E
Director
- 5250
60 USD
2 years ago
Jul 05, 2022
Sell 315 K USD
Kiernan Jane E
Director
- 5250
60 USD
2 years ago
Mar 29, 2022
Sell 3 M USD
COHEN RAYMOND W
director: Chief Executive Officer
- 50000
60 USD
2 years ago
Mar 29, 2022
Sell 210 K USD
Kiernan Jane E
director:
- 3500
60 USD
2 years ago
Mar 29, 2022
Sell 108 K USD
Kiernan Jane E
Director
- 1750
61.4897 USD
2 years ago
Mar 18, 2022
Sell 774 K USD
Noblett Karen
director: Chief Medical Officer
- 13531
57.2285 USD
2 years ago
Mar 14, 2022
Sell 897 K USD
COHEN RAYMOND W
Chief Executive Officer
- 17787
50.4184 USD
2 years ago
Mar 14, 2022
Sell 108 K USD
COHEN RAYMOND W
director: Chief Executive Officer
- 2100
51.4001 USD
2 years ago
Mar 14, 2022
Sell 104 K USD
COHEN RAYMOND W
Chief Executive Officer
- 1981
52.6584 USD
2 years ago
Mar 14, 2022
Sell 606 K USD
COHEN RAYMOND W
Chief Executive Officer
- 11232
53.9533 USD
2 years ago
Mar 14, 2022
Sell 926 K USD
COHEN RAYMOND W
Chief Executive Officer
- 16900
54.7986 USD
2 years ago
Mar 01, 2022
Sell 614 K USD
Dearen Danny L.
director: See Remarks
- 10564
58.1137 USD
2 years ago
Feb 25, 2022
Sell 570 K USD
Dearen Danny L.
- 10000
57 USD
2 years ago
Feb 03, 2022
Sell 306 K USD
Noblett Karen
- 6343
48.2103 USD
2 years ago
Feb 03, 2022
Sell 16.6 K USD
Noblett Karen
- 339
49.0347 USD
2 years ago
Feb 03, 2022
Sell 544 K USD
Sama Rinda
- 11280
48.2103 USD
2 years ago
Feb 03, 2022
Sell 29.5 K USD
Sama Rinda
- 602
49.0347 USD
2 years ago
Feb 03, 2022
Sell 286 K USD
Woock John
- 5934
48.2103 USD
2 years ago
Feb 03, 2022
Sell 15.5 K USD
Woock John
- 317
49.0347 USD
2 years ago
Feb 03, 2022
Sell 424 K USD
Ford Alfred J Jr
- 8797
48.2103 USD
2 years ago
Feb 03, 2022
Sell 23 K USD
Ford Alfred J Jr
- 470
49.0347 USD
2 years ago
Feb 03, 2022
Sell 855 K USD
Dearen Danny L.
- 17737
48.2103 USD
2 years ago
Feb 03, 2022
Sell 46.4 K USD
Dearen Danny L.
- 947
49.0347 USD
2 years ago
Feb 01, 2022
Sell 94.5 K USD
Dearen Danny L.
- 2017
46.828 USD
2 years ago
Feb 01, 2022
Sell 180 K USD
Dearen Danny L.
- 3730
48.2572 USD
2 years ago
Feb 01, 2022
Sell 680 K USD
Dearen Danny L.
- 13853
49.0665 USD
2 years ago
Feb 01, 2022
Sell 19.9 K USD
Dearen Danny L.
- 400
49.695 USD
2 years ago
Feb 03, 2022
Sell 1.61 M USD
COHEN RAYMOND W
- 33336
48.2103 USD
2 years ago
Feb 03, 2022
Sell 87.2 K USD
COHEN RAYMOND W
- 1779
49.0347 USD
2 years ago
Jan 18, 2022
Sell 214 K USD
Dearen Danny L.
- 4312
49.7281 USD
2 years ago
Jan 18, 2022
Sell 496 K USD
Dearen Danny L.
- 9756
50.8044 USD
2 years ago
Jan 18, 2022
Sell 201 K USD
Dearen Danny L.
- 3886
51.681 USD
2 years ago
Jan 18, 2022
Sell 108 K USD
Dearen Danny L.
- 2046
52.6063 USD
3 years ago
Nov 15, 2021
Sell 121 K USD
Woock John
- 2016
60.1235 USD
3 years ago
Nov 15, 2021
Sell 181 K USD
Woock John
- 2984
60.7279 USD
3 years ago
Sep 09, 2021
Sell 3.86 M USD
COHEN RAYMOND W
- 50000
77.107 USD
3 years ago
Sep 01, 2021
Sell 631 K USD
Woock John
- 8443
74.7264 USD
3 years ago
Sep 02, 2021
Sell 118 K USD
Woock John
- 1557
75.5793 USD
3 years ago
Aug 17, 2021
Sell 357 K USD
Woock John
- 5398
66.179 USD
3 years ago
Aug 17, 2021
Sell 903 K USD
Woock John
- 13501
66.8479 USD
3 years ago
Aug 17, 2021
Sell 401 K USD
Woock John
- 5901
68.0387 USD
3 years ago
Aug 17, 2021
Sell 13.8 K USD
Woock John
- 200
69.05 USD
3 years ago
Jun 11, 2021
Sell 158 K USD
Sama Rinda
- 2638
59.78 USD
3 years ago
Jun 10, 2021
Sell 81.7 K USD
Sama Rinda
- 1362
60.0195 USD
3 years ago
Jun 08, 2021
Sell 60.2 K USD
Sama Rinda
- 1000
60.234 USD
3 years ago
Jun 08, 2021
Sell 2 M USD
COHEN RAYMOND W
- 33333
60 USD
3 years ago
May 20, 2021
Sell 1.01 M USD
Dearen Danny L.
- 18516
54.4537 USD
3 years ago
May 21, 2021
Sell 379 K USD
Dearen Danny L.
- 6866
55.2234 USD
3 years ago
May 20, 2021
Sell 1.36 M USD
Dearen Danny L.
- 24618
55.0465 USD
3 years ago
May 18, 2021
Sell 1.81 M USD
COHEN RAYMOND W
- 32833
55 USD
3 years ago
May 11, 2021
Sell 1.07 M USD
Sama Rinda
- 20162
53.0917 USD
3 years ago
May 11, 2021
Sell 263 K USD
Sama Rinda
- 4838
54.4039 USD
3 years ago
May 10, 2021
Sell 695 K USD
COHEN RAYMOND W
- 13109
52.9816 USD
3 years ago
May 10, 2021
Sell 972 K USD
COHEN RAYMOND W
- 17954
54.1271 USD
3 years ago
May 10, 2021
Sell 152 K USD
COHEN RAYMOND W
- 2770
54.8102 USD
3 years ago
Apr 21, 2021
Sell 155 K USD
Dearen Danny L.
- 2572
60.2964 USD
3 years ago
Apr 21, 2021
Sell 886 K USD
Dearen Danny L.
- 14382
61.5835 USD
3 years ago
Apr 20, 2021
Sell 4.26 M USD
Dearen Danny L.
- 73231
58.1411 USD
3 years ago
Apr 21, 2021
Sell 500 K USD
Dearen Danny L.
- 8046
62.1497 USD
3 years ago
Apr 20, 2021
Sell 104 K USD
Dearen Danny L.
- 1769
58.6141 USD
3 years ago
Apr 19, 2021
Sell 2.44 M USD
Ford Alfred J Jr
- 41794
58.3268 USD
3 years ago
Apr 19, 2021
Sell 742 K USD
Ford Alfred J Jr
- 12502
59.3262 USD
3 years ago
Apr 15, 2021
Sell 2.05 M USD
Sama Rinda
- 35127
58.4489 USD
3 years ago
Apr 15, 2021
Sell 876 K USD
Sama Rinda
- 14873
58.8661 USD
3 years ago
Apr 15, 2021
Sell 1.43 M USD
Sama Rinda
- 23848
60.0823 USD
3 years ago
Apr 16, 2021
Sell 69.2 K USD
Sama Rinda
- 1152
60.0661 USD
3 years ago
Feb 25, 2021
Sell 240 K USD
Woock John
- 4771
50.3972 USD
3 years ago
Feb 25, 2021
Sell 268 K USD
Woock John
- 5229
51.2048 USD
3 years ago
Feb 01, 2021
Sell 89.9 K USD
Ford Alfred J Jr
- 1751
51.3645 USD
3 years ago
Feb 01, 2021
Sell 6.88 K USD
Ford Alfred J Jr
- 132
52.1179 USD
3 years ago
Feb 01, 2021
Sell 204 K USD
Sama Rinda
- 3964
51.3645 USD
3 years ago
Feb 01, 2021
Sell 15.5 K USD
Sama Rinda
- 298
52.1179 USD
3 years ago
Feb 01, 2021
Sell 347 K USD
Dearen Danny L.
- 6751
51.3645 USD
3 years ago
Feb 01, 2021
Sell 26.4 K USD
Dearen Danny L.
- 507
52.1179 USD
3 years ago
Feb 01, 2021
Sell 651 K USD
COHEN RAYMOND W
- 12675
51.3645 USD
3 years ago
Feb 01, 2021
Sell 49.6 K USD
COHEN RAYMOND W
- 952
52.1179 USD
3 years ago
Feb 01, 2021
Sell 98.5 K USD
Woock John
- 1917
51.3645 USD
3 years ago
Jan 28, 2021
Sell 399 K USD
Woock John
- 7571
52.7457 USD
3 years ago
Jan 28, 2021
Sell 383 K USD
Woock John
- 7129
53.6898 USD
3 years ago
Jan 28, 2021
Sell 16.3 K USD
Woock John
- 300
54.4302 USD
3 years ago
Jan 26, 2021
Sell 172 K USD
Sama Rinda
director: Chief Operating Officer
- 3217
53.5766 USD
3 years ago
Jan 26, 2021
Sell 101 K USD
Woock John
- 1893
53.5766 USD
3 years ago
Jan 26, 2021
Sell 129 K USD
Ford Alfred J Jr
Chief Commercial Officer
- 2417
53.5766 USD
3 years ago
Jan 26, 2021
Sell 129 K USD
Ford Alfred J Jr
director: Chief Commercial Officer
- 2417
53.5766 USD
3 years ago
Jan 26, 2021
Sell 243 K USD
Dearen Danny L.
- 4541
53.5766 USD
3 years ago
Jan 26, 2021
Sell 420 K USD
COHEN RAYMOND W
- 7842
53.5766 USD
3 years ago
Jan 13, 2021
Sell 475 K USD
MCNAMARA ROBERT E
- 9167
51.8308 USD
3 years ago
Dec 08, 2020
Sell 406 K USD
Sama Rinda
- 8763
46.3134 USD
3 years ago
Nov 27, 2020
Sell 105 K USD
Woock John
- 2400
43.7946 USD
3 years ago
Nov 27, 2020
Sell 4.55 K USD
Woock John
- 100
45.49 USD
3 years ago
Nov 27, 2020
Sell 337 K USD
Woock John
- 7500
44.9414 USD
3 years ago
Nov 25, 2020
Sell 439 K USD
Sama Rinda
- 10000
43.9142 USD
4 years ago
Nov 04, 2020
Sell 130 K USD
Sama Rinda
- 2600
50.1206 USD
4 years ago
Oct 29, 2020
Sell 296 K USD
Sama Rinda
director: Chief Operating Officer
- 6200
47.7129 USD
4 years ago
Oct 29, 2020
Sell 183 K USD
Sama Rinda
director: Chief Operating Officer
- 3800
48.1247 USD
4 years ago
Oct 29, 2020
Sell 139 K USD
Sama Rinda
director: Chief Operating Officer
- 2863
48.6 USD
4 years ago
Oct 30, 2020
Sell 289 K USD
Sama Rinda
director: Chief Operating Officer
- 6037
47.8056 USD
4 years ago
Oct 30, 2020
Sell 53.4 K USD
Sama Rinda
director: Chief Operating Officer
- 1100
48.5427 USD
4 years ago
Nov 03, 2020
Sell 15 K USD
Sama Rinda
director: Chief Operating Officer
- 300
50 USD
4 years ago
Sep 18, 2020
Sell 391 K USD
Tammenoms Bakker Juliet
Director
- 9167
42.666 USD
4 years ago
Sep 02, 2020
Sell 440 K USD
Ford Alfred J Jr
- 11031
39.8447 USD
4 years ago
Sep 02, 2020
Sell 959 K USD
Ford Alfred J Jr
- 23743
40.4062 USD
4 years ago
Aug 31, 2020
Sell 113 K USD
Ford Alfred J Jr
- 2667
42.3116 USD
4 years ago
Sep 02, 2020
Sell 9.34 K USD
Ford Alfred J Jr
- 226
41.3229 USD
4 years ago
Aug 28, 2020
Sell 217 K USD
Woock John
- 5000
43.4534 USD
4 years ago
Aug 28, 2020
Sell 217 K USD
Woock John
- 5000
43.4502 USD
4 years ago
Aug 14, 2020
Sell 103 K USD
Tammenoms Bakker Juliet
Director
- 2393
43.2186 USD
4 years ago
Aug 07, 2020
Sell 696 K USD
COHEN RAYMOND W
- 16633
41.824 USD
4 years ago
Aug 07, 2020
Sell 144 K USD
COHEN RAYMOND W
- 3367
42.7455 USD
4 years ago
Aug 11, 2020
Sell 211 K USD
COHEN RAYMOND W
- 5159
40.9541 USD
4 years ago
Aug 11, 2020
Sell 370 K USD
COHEN RAYMOND W
- 8808
42.0534 USD
4 years ago
Aug 11, 2020
Sell 472 K USD
COHEN RAYMOND W
- 11033
42.776 USD
4 years ago
Aug 06, 2020
Sell 699 K USD
Sama Rinda
director: Chief Operating Officer
- 16173
43.2485 USD
4 years ago
Aug 06, 2020
Sell 155 K USD
Sama Rinda
director: Chief Operating Officer
- 3527
43.9381 USD
4 years ago
Aug 06, 2020
Sell 13.5 K USD
Sama Rinda
director: Chief Operating Officer
- 300
44.9667 USD
4 years ago
Aug 07, 2020
Sell 401 K USD
Sama Rinda
director: Chief Operating Officer
- 9367
42.827 USD
4 years ago
Aug 07, 2020
Sell 266 K USD
Sama Rinda
director: Chief Operating Officer
- 6073
43.8546 USD
4 years ago
Aug 07, 2020
Sell 458 K USD
Sama Rinda
director: Chief Operating Officer
- 10260
44.6568 USD
4 years ago
Aug 07, 2020
Sell 196 K USD
Sama Rinda
director: Chief Operating Officer
- 4300
45.5958 USD
4 years ago
Jul 28, 2020
Sell 591 K USD
Sama Rinda
- 13708
43.1033 USD
4 years ago
Jul 29, 2020
Sell 55.6 K USD
Sama Rinda
- 1292
43 USD
4 years ago
Jul 21, 2020
Sell 423 K USD
Sama Rinda
- 10400
40.6934 USD
4 years ago
Jul 20, 2020
Sell 775 K USD
Sama Rinda
- 19700
39.3326 USD
4 years ago
Jul 20, 2020
Sell 36.2 K USD
Sama Rinda
- 900
40.1894 USD
4 years ago
Jul 21, 2020
Sell 164 K USD
Sama Rinda
- 4000
41.0999 USD
4 years ago
Jul 15, 2020
Sell 333 K USD
COHEN RAYMOND W
director: Chief Executive Officer
- 8628
38.5465 USD
4 years ago
Jul 15, 2020
Sell 333 K USD
COHEN RAYMOND W
Chief Executive Officer
- 8628
38.5465 USD
4 years ago
Jul 15, 2020
Sell 613 K USD
COHEN RAYMOND W
director: Chief Executive Officer
- 15472
39.6073 USD
4 years ago
Jul 15, 2020
Sell 613 K USD
COHEN RAYMOND W
Chief Executive Officer
- 15472
39.6073 USD
4 years ago
Jul 15, 2020
Sell 35.9 K USD
COHEN RAYMOND W
Chief Executive Officer
- 900
39.9372 USD
4 years ago
Jul 15, 2020
Sell 35.9 K USD
COHEN RAYMOND W
director: Chief Executive Officer
- 900
39.9372 USD
4 years ago
Jul 16, 2020
Sell 991 K USD
COHEN RAYMOND W
Chief Executive Officer
- 25000
39.6507 USD
4 years ago
Jul 16, 2020
Sell 991 K USD
COHEN RAYMOND W
director: Chief Executive Officer
- 25000
39.6507 USD
4 years ago
Jul 13, 2020
Sell 1 M USD
COHEN RAYMOND W
- 24800
40.3444 USD
4 years ago
Jul 13, 2020
Sell 8.22 K USD
COHEN RAYMOND W
- 200
41.1 USD
4 years ago
Jul 14, 2020
Sell 912 K USD
COHEN RAYMOND W
- 25000
36.4909 USD
4 years ago
Jul 07, 2020
Sell 28.4 K USD
Dearen Danny L.
director: See Remarks
- 709
40 USD
4 years ago
Jun 18, 2020
Sell 1.18 M USD
Dearen Danny L.
- 30000
39.2627 USD
4 years ago
Jun 22, 2020
Sell 1.71 M USD
Dearen Danny L.
- 45000
38.1106 USD
4 years ago
May 19, 2020
Sell 780 USD
Sama Rinda
- 20
39 USD
4 years ago
May 15, 2020
Sell 525 K USD
Dearen Danny L.
- 15000
35.0295 USD
4 years ago
May 15, 2020
Sell 529 K USD
Dearen Danny L.
- 15000
35.2367 USD
4 years ago
May 18, 2020
Sell 559 K USD
Dearen Danny L.
- 15000
37.2561 USD
4 years ago
May 19, 2020
Sell 601 K USD
Dearen Danny L.
- 15000
40.0518 USD
4 years ago
May 11, 2020
Sell 456 K USD
Dearen Danny L.
- 13100
34.7832 USD
4 years ago
May 11, 2020
Sell 65 K USD
Dearen Danny L.
- 1900
34.2172 USD
4 years ago
May 14, 2020
Sell 679 K USD
Dearen Danny L.
- 19871
34.1831 USD
4 years ago
May 14, 2020
Sell 4.45 K USD
Dearen Danny L.
- 129
34.53 USD
4 years ago
May 11, 2020
Sell 525 K USD
Dearen Danny L.
- 15000
35.018 USD
4 years ago
Mar 02, 2020
Sell 153 K USD
Dearen Danny L.
- 4147
37 USD
4 years ago
Feb 26, 2020
Sell 296 K USD
Dearen Danny L.
director: See Remarks
- 8000
37.0077 USD
4 years ago
Feb 26, 2020
Sell 291 K USD
Dearen Danny L.
director: See Remarks
- 7853
37.0066 USD
4 years ago
Feb 13, 2020
Sell 3.5 K USD
Dearen Danny L.
- 103
34 USD
4 years ago
Feb 18, 2020
Sell 685 K USD
Dearen Danny L.
- 20000
34.25 USD
4 years ago
Jan 23, 2020
Sell 629 K USD
Dearen Danny L.
- 20000
31.4578 USD
4 years ago
Apr 30, 2020
Sell 161 K USD
Sama Rinda
- 5000
32.2029 USD
4 years ago
Apr 02, 2020
Sell 119 K USD
Sama Rinda
- 5000
23.72 USD
4 years ago
Mar 16, 2020
Sell 715 K USD
COHEN RAYMOND W
- 34269
20.8716 USD
4 years ago
Mar 16, 2020
Sell 149 K USD
COHEN RAYMOND W
- 6955
21.4795 USD
4 years ago
Mar 05, 2020
Sell 191 K USD
Sama Rinda
- 5000
38.12 USD
4 years ago
Mar 02, 2020
Sell 153 K USD
Dearen Danny L.
- 4147
37 USD
4 years ago
Feb 26, 2020
Sell 296 K USD
Dearen Danny L.
director: See Remarks
- 8000
37.0077 USD
4 years ago
Feb 26, 2020
Sell 291 K USD
Dearen Danny L.
director: See Remarks
- 7853
37.0066 USD
4 years ago
Feb 25, 2020
Sell 359 K USD
Woock John
- 10000
35.8726 USD
4 years ago
Feb 13, 2020
Sell 332 K USD
COHEN RAYMOND W
- 10000
33.2065 USD
4 years ago
Feb 13, 2020
Sell 3.5 K USD
Dearen Danny L.
- 103
34 USD
4 years ago
Feb 18, 2020
Sell 685 K USD
Dearen Danny L.
- 20000
34.25 USD
4 years ago
Feb 06, 2020
Sell 146 K USD
Sama Rinda
- 5000
29.1377 USD
7. News
Boston Scientific Closes Acquisition of Axonics, Inc. MARLBOROUGH, Mass. , Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. prnewswire.com - 2 days ago
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ago. zacks.com - 1 week ago
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device AXNX's R20 rechargeable SNM system, offering long-lasting treatment for bladder and bowel dysfunction, gains approval in Australia. zacks.com - 1 month ago
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder and fecal incontinence. The R20 neurostimulator is labeled for a functional life in the body of at least 20 years and reduces how frequently a patient needs to recharge their implanted device to once. businesswire.com - 1 month ago
Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic AXNX stock continues to gain following a favorable court ruling last week in a patent litigation with Medtronic. zacks.com - 1 month ago
Axonics Prevails in Patent Infringement Lawsuit with Medtronic IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Central District of California. The jury found that Axonics does not infringe any of the three patents-in-suit. “A jury of our peers recognized that Axonics' proprietary tined lead design and temperature sensor technology is differentiated from our competitor's intellect. businesswire.com - 1 month ago
Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.15 per share a year ago. zacks.com - 3 months ago
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Amalgamated Bank Amalgamated Bank cut its holdings in shares of Axonics, Inc. (NASDAQ:AXNX – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,052 shares of the company’s stock after selling 499 shares during the period. Amalgamated Bank’s holdings in Axonics were worth $439,000 at the end of the most recent quarter. Several other institutional investors and hedge funds have also added to or reduced their stakes in AXNX. Headlands Technologies LLC acquired a new stake in shares of Axonics during the fourth quarter valued at approximately $53,000. RiverPark Advisors LLC acquired a new stake in shares of Axonics during the third quarter valued at approximately $58,000. C M Bidwell & Associates Ltd. raised its holdings in shares of Axonics by 108.2% during the third quarter. C M Bidwell & Associates Ltd. now owns 1,270 shares of the company’s stock valued at $71,000 after acquiring an additional 660 shares during the period. Sentry Investment Management LLC acquired a new stake in shares of Axonics during the fourth quarter valued at approximately $125,000. Finally, Covestor Ltd raised its holdings in shares of Axonics by 40.8% during the third quarter. Covestor Ltd now owns 3,143 shares of the company’s stock valued at $176,000 after acquiring an additional 911 shares during the period. 99.48% of the stock is owned by institutional investors and hedge funds. Axonics Stock Down 0.2 % AXNX stock opened at $67.55 on Monday. The company has a market capitalization of $3.45 billion, a price-to-earnings ratio of -211.09 and a beta of 0.60. Axonics, Inc. has a 12 month low of $47.59 and a 12 month high of $69.68. The firm has a 50 day moving average of $67.72 and a two-hundred day moving average of $64.46. Axonics (NASDAQ:AXNX – Get Free Report) last posted its earnings results on Tuesday, April 30th. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.32). The business had revenue of $91.41 million during the quarter, compared to the consensus estimate of $89.79 million. Axonics had a negative return on equity of 2.58% and a negative net margin of 4.12%. The business’s revenue was up 29.4% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.19) earnings per share. On average, research analysts expect that Axonics, Inc. will post 0.13 EPS for the current fiscal year. Wall Street Analysts Forecast Growth AXNX has been the topic of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Axonics in a report on Monday, May 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $71.00 price objective on shares of Axonics in a research note on Thursday, February 29th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $70.73. Read Our Latest Analysis on Axonics Axonics Profile (Free Report) Axonics, Inc, a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. https://www.defenseworld.net - 5 months ago
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder. “Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said Dr. Ailsa Wilson Edwards, a urologist at Calvary North Adelaide Hospital. “I. businesswire.com - 6 months ago
Axonics Reports First Quarter 2024 Financial Results IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024. “Our commercial team continued to execute at a high level in the first quarter, generating revenue growth of 29% year over year across our portfolio of incontinence products,” said Raymond W. Cohen, chief executive. businesswire.com - 6 months ago
Boston Scientific Announces Results for First Quarter 2024 MARLBOROUGH, Mass. , April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. prnewswire.com - 6 months ago
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal Boston Scientific said on Thursday the U.S. Federal Trade Commission (FTC) has requested additional information from the medical device maker related to its $3.7 billion deal to buy Axonics. reuters.com - 7 months ago
8. Profile Summary

Axonics, Inc. AXNX

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 3.63 B
Dividend Yield 0.00%
Description Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Contact 26 Technology Drive, Irvine, CA, 92618 https://www.axonics.com
IPO Date Oct. 31, 2018
Employees 797
Officers Ms. Kari Keese Chief Financial Officer Mr. Michael V. Williamson Esq., J.D. Senior Vice President, General & IP Counsel Mr. Aaron Pettit General Counsel & Chief Compliance Officer Mr. Raymond W. Cohen Chief Executive Officer & Director Mr. Rinda K. Sama Chief Operating Officer Dr. John Woock Ph.D. Executive Vice President, Chief Marketing & Strategy Officer Mr. Alfred J. Ford Jr. Chief Commercial Officer Mr. Guangqiang Jiang Ph.D. Chief Technology Officer Mr. Neil Bhalodkar Vice President of Investor Relations Dr. Karen L. Noblett M.A.S., M.D. Chief Medical Officer